Sanofi

NYSE

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Novavax,Vaccine,For,Prevention,Of,Coronavirus,,Covid-19,,Sars-cov-2,In,Doctors

News

BNTX

MRNA

NVAX

Novavax&#39;s COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment

Gentilly,,France,,March,21,,2021:,Sign,And,Logo,On,The

Biotech

Large Cap

Health Care

Movers

Trading Ideas

General

REGN

RHHBY

Sanofi plans $20 billion US investment by 2030 to expand R&amp;D and manufacturing, aiming to boost medicine production and job creation across states.

Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030

Rueil-malmaison,,France,-,August,13,,2023:,French,Headquarters,Of,Bristol-myers

Legal

Bristol-Myers Squibb will pay $350 million to settle Hawaii&#39;s lawsuit over Plavix marketing practices, ending claims without admitting wrongdoing and avoiding trial.

Bristol-Myers Squibb Strikes $350 Million Deal To End Hawaii&#39;s Plavix Lawsuit

Sanofi SA

Synthetify

SUNNYLIFE GLOBAL INC by Sunnylife Global, Inc.

Sunnylife Global Inc

Synergy CHC Corp

VITAL ENERGY INC (CDA) by Vital Energy, Inc.

Vital Energy Inc

SANY HEAVY EQUIP INTL HLD by Sany Heavy Equipment International Holdings Co.

Sany Heavy Equipment International Holdings Co Ltd

Opinion

Press Releases

Global Cancer Rates Surge as Biotech Innovators Work on New Therapies

Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies

FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals

Beyfortus® immunization to protect infants from RSV has begun

Penny Stocks

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing

Viz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease (COPD)

AVTE

CTRX

DVAX

GTHX

HALO

HPTX

HZNP

ONCY

TARS

TSX:ONC

ZNTL

ZSPH

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Takeda Pharmaceutical Co

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Indus

Verona Pharma plc - American Depositary Shares

Verona Pharma

Viatris

Zoetis

Goldman Sachs

Argus Research

Morgan Stanley

Screenshot 2025-03-12 at 4.47.01 PM

AMGN

BIIB

ELDN

TNXP

Tonix&#39;s TNX-1500 Shows Promise In Preventing Organ Transplant Rejections Of Either Human Or Pig Organs; Autoimmune Diseases Also A Target

Redington 2_29

BDRX

PowerShares Dynamic Financial Sector Portfolio

Comments

Sanofi

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell